Aim: Skeletal muscle is a heterogeneous tissue containing several different cell types, and only about 40%-50% of the cell nuclei within the tissue belong to myofibres. Existing technology, attempting to distinguish myonuclei from other nuclei at the light microscopy level, has led to controversies in our understanding of the basic cell biology of muscle plasticity. This study aims at demonstrating that an antibody against the protein pericentriolar material 1 (PCM1) can be used to reliably identify myonuclei on histological cross sections from humans, mice and rats. Methods: Cryosections were labelled with a polyclonal antibody against PCM1.
| INTRODUCTION
Most tissues are heterogeneous, and this represents an inherent problem when analysing homogenates or even histological sections at the light microscopy level. The latter has been solved in many systems using cell-specific or organelle-specific antibodies.
Skeletal muscle tissue is also heterogeneous and contains long multinucleated cells called myofibres, fibroblasts in the connective tissues, various cells in the blood vessels and the myogenic stem cells called satellite cells. The satellite cells are the source of new myonuclei for growing and regenerating muscle fibres and were originally identified by electron microscopy (EM). 1 They are particularly difficult to distinguish from the myonuclei as they reside between the basal lamina and cell membrane of the muscle fibres.
Only the nuclei inside the muscle fibre sarcolemma contribute to their protein expression and are defined as true myonuclei. Depending on the muscle being analysed, electron microscopy has revealed that only approx 40%-50% of the nuclei found in muscle tissue are myonuclei, 2 but so far there has been no generally accepted immunohistochemical marker to discern these nuclei at the light microscopy level. While EM, 2 and in vivo imaging, [3] [4] [5] [6] [7] [8] [9] can be used to reliably identify myonuclei, analysis of tissue sections using regular light microscopy has led to conflicting results in the understanding of how myonuclei are related to cell size regulation as we have discussed previously. 10, 11 The standard model for size regulation has implied that when muscle fibres grow, hypertrophic satellite cells fuse to the enlarged fibres to support the larger cytoplasm. Conversely, during atrophy, some of the myonuclei inside the intact fibres are allegedly lost by a nuclear apoptotic process as the cell is returning to a state of a smaller calibre with fewer nuclei (reviewed in 12 ).
This model is to a large extent based on histology with classical chemical staining methods and has recently been challenged by direct observation of myonuclei by in vivo imaging (reviewed in 10, 12 ). The new results indicate that recruitment of myonuclei precedes cell enlargement 7 and is obligatory at least for major de novo hypertrophy, 9, 13, 14 and in direct conflict with the old model, myonuclei are not lost during atrophy. 6, 11 The "extra" nuclei that have been acquired by previous hypertrophy seem to be permanent and are aiding in a more rapid subsequent regrowth. This was the foundation of the recent proposal of a cellular memory in muscle. 8 Using dystrophin staining to label the fibre cortex and determining which nuclei are within the dystrophin ring of fibre cross sections can result in data consistent with those obtained by in vivo imaging. But even this approach has led to conflicting findings. [15] [16] [17] To identify myonuclei specifically, a strict and cumbersome evaluation procedure for each nucleus should be used. This has not been adhered to in most of the literature, and even when it is, the method is very sensitive for small and subjective differences. Thus, in our laboratory, when the same unbiased operator evaluated the same sections, but were instructed to count only the nuclei with their geometric centre inside the dystrophin ring, the number of nuclei was significantly reduced compared to the number obtained when also nuclei with their centre on the ring was included.
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In our previous histological studies, we have consistently defined myonuclei as nuclei with their geometrical centre inside the inner rim of the dystrophin ring. 6, 7, 10, 11 While this has given results consistent with in vivo imaging data, we have been worried that the criterion is too strict and that some myonuclei were not identified as such (false negatives).
In dividing cells, the protein pericentriolar material 1 (PCM1) is associated with the centrosome where it is important for microtubule organization and centrosome proteostasis. [18] [19] [20] In differentiated post-mitotic myocytes, the protein relocalizes to the nuclear envelope where it forms an insoluble matrix. [21] [22] [23] As myonuclei are in a post-mitotic state, PCM1 is found on the nuclear envelope in adult skeletal muscle. 22, 23 An antibody against PCM1 has been used for identifying cardiomyocyte nuclei, 24 and we hypothesized that PCM1 could be used as a novel marker to identify skeletal muscle myonuclei at the light microscopy level. We report here that PCM1 specifically labelled myonuclei, and not the nuclei belonging to satellite cells or other cell types in human and rodent muscle tissue.
| RESULTS

| PCM1 selectively labelled myonuclei
To investigate whether PCM1 could be used as a marker for myonuclei, we stained cross sections of skeletal muscles from humans, mice and rats with DAPI, dystrophin and PCM1. Detailed inspection of the sections in several confocal planes showed that all nuclei inside the dystrophin ring were positive for PCM1 in all three species. The confocal stack analysis was performed on 689 nuclei from 3 mice (Figure 1 ) 323 nuclei from 4 humans (Figure 2A-C) , and 286 nuclei from 3 rats ( Figure 2D ).
In some cases, separating individual nuclei was difficult, especially when they were partly overlapping, but in different z-planes. An example is shown in Figure 1B . Inspection of their position using confocal 3D rendering revealed that these were indeed separate nuclei, one being labelled for PCM1 ( Figure 1C) . In some cases, PCM1-positive nuclei appeared to be outside the dystrophin ring (Figure 1B and 2B ), but closer inspection of their position using confocal z-stacks confirmed that they were indeed situated inside the dystrophin ring ( Figure 1C and 2C ). Using these methods for screening a total of 1298 PCMpositive nuclei from 13 muscles in the three species, we did not find any PCM1-positive nuclei that appeared to be outside the dystrophin ring, and all the DAPI-positive nuclei inside the ring co-stained for PCM1.
We then selected 3 random images from the data material in Figure 1 , and all DAPI-positive nuclei structures were evaluated for PCM1 labelling. In EDL and soleus 1034 and 1129, DAPI-positive structures were scrutinized in this way, excluding veins and large non-myofibrillar bodies. We found that 50% and 46% of the DAPI-positive structures were PCM1 positive in EDL and soleus respectively. Such fractions of myonuclear nuclei of the total number of nuclei are similar to those inferred from EM images from fast and slow muscles. 2 Finally, we used the same images to compare PCM1 labelling and a purely positional method. As described in the Introduction, we have previously defined myonuclei as nuclei with their geometrical centre inside the inner rim of the dystrophin ring as judged by non-confocal imaging. 6, 7, 10, 11 We here used the same method using one confocal plane. When analysed in this way, we deemed 248 and 314 nuclei to fill the positional criteria for a myonucleus, while 287 and 348 nuclei were PCM1 positive in EDL and soleus respectively. Thus, the number of PCM1-positive nuclei was 16% and 11% higher (Figure 3A) . When the discordant nuclei were analysed in several focal planes, it was confirmed that all these PCM1-positive nuclei were indeed inside the dystrophin ring (Figure 3B ,C). This suggests that the purely positional method is too conservative when only one image plane is used.
| PCM1 co-localized with myonucleispecific mCherry expression
To further validate that PCM1 labels all myonuclei, we investigated the localization of PCM1 by the aid of viral transduction of a mCherry construct fused to a nuclear localization signal peptide under the control of the muscle-specific Alpha-Actin-1 (ACTA1) promoter ( Figure 4A ). Analysis of cross sections stained for dystrophin and visualised for mCherry showed that we transduced approx 20% of the muscle fibres. Of 165 nuclei (n = 3 mice) labelled with mCherry, all were found inside of the dystrophin ring and hence were myonuclei ( Figure 4B ). This was followed by inspection of the co-localization of PCM1 and mCherry revealing that all mCherry-verified myonuclei were found to be positive for PCM1 staining ( Figure 4C ). In addition, the PCM1 antibody labelled a band with the size corresponding to PCM1 ( Figure 4D ) 25 Additional analyses of the soluble and insoluble fraction of the muscle lysate showed that PCM1 localized to the insoluble fraction, consistent with the interpretation that PCM1 is localized to the nuclear membrane. 
| PCM1 did not label satellite cells
Satellite cells are activated during repair and hypertrophy and will then increase in number as a source for new myonuclei. We were concerned that PCM1 might label satellite cells and give rise to false positives. Additionally, the intimate association with the sarcolemma makes it difficult to discern these nuclei using positional methods. On sections triple-labelled for PCM1, PAX7 and DNA, we screened 24 PAX7 positive nuclei, and none of them stained for PCM1 ( Figure 5 ). For this experiment, overloaded muscles were used to increase the number of satellite cells (PAX7-positive), as during basal conditions the number of PAX7-positive satellite cells detected on muscle cross sections is very low.
| PCM1 labelled all the myonuclei of overloaded muscles
We next investigated whether the PCM1 antibody would also label myonuclei inserted during hypertrophy by overloading soleus by synergist ablation. 8 Muscle cross sections were stained with the PCM1 antibody after 14 days of overload, revealing a 16% increase in PCM1-positive nuclei and a 14% increase in fibre crosssectional area compared to contralateral control muscles ( Figure 6 ). Like in naive muscles, essentially all the nuclei inside the dystrophin ring were PCM1 positive. This F I G U R E 3 Quantification of myonuclear number using different methods. A, Number of nuclei assessed as myonuclei using either DAPI positive with its mass centre inside the dystrophin ring or being pericentriolar material 1 (PCM1) and DAPI positive. Images (two per muscle) were assessed with (PCM1) and without (DAPI) the PCM1 channel in mice soleus (n = 3 animals, 287 nuclei) and EDL (n = 3 animals, 348 nuclei) muscles. Bars showing mean with 95% CI (B) Micrographs from different z-planes illustrating how the same nucleus can appear both inside (+4 lm) and outside (0 lm and À1 lm) the dystrophin ring. C, Longitudinal section showing local bulging of the dystrophin around the myonucleus. Scale bar: 20 lm for (B) and 10 lm for (C) indicates that the PCM1 antibody also labelled the newly recruited myonuclei under these experimental conditions.
| DISCUSSION
In the present study, we show that a PCM1 antibody specifically labels all myonuclei and myonuclei only in cryosections of rats, mice and men. Importantly, by Pax7 co-staining, it was determined that PCM1 did not label satellite cells which are particularly difficult to discern due to its close proximity to the muscle fibres. Thus, PCM1 can be used as a histological marker for this subset of nuclei in skeletal muscle tissue without relying on counterstaining of other structures or cumbersome and subjective analysis of nuclear positioning sometimes at the limit of the microscopical resolution.
There has been no established gold standard for identifying myonuclei in histological sections, but the best practice has been based on labelling all the nuclei in the tissue with a DNA stain, and then identifying the myonuclei by their position relative to the dystrophin labelling of the fibre cortex cytoskeleton (see, eg, [6] [7] [8] [9] [10] [11] [15] [16] [17] [26] [27] [28] ).
Besides the subjectivity in assessing the position of the myonuclei, our confocal analysis demonstrates that small deviations in the angle of the nuclei relative to the section plane may result in individual nuclei appearing to be positioned in, on or outside the fibre boundary, and as dystrophin localizes in distinct subsarcolemmal domains in mammalian skeletal muscle, local folds and tissue conditions may result in a broader appearance of the dystrophin ring when being analysed on sections. 29 The number of PCM1-labelled nuclei was 11%-16% higher than the number of myonuclei observed with their geometric centre inside the inner rim of the dystrophin ring by non-confocal imaging. By a detailed analysis of several confocal planes through the sections, it was confirmed that these nuclei were in fact also inside the dystrophin ring and that the inclusion criterion using geometric centres was too strict so that not all myonuclei were included, for example false negatives. While false negatives might distort absolute numbers, they probably represent a random subpopulation of nuclei and would not distort conclusions about myonuclear behaviour.
In most of the existing literature, no explicit precise criteria for determining the nuclear position nor a closer 3D evaluation has been used, and this might have led to inclusion of nuclei that were not true myonuclei, that is false positives. This is a more serious problem than false negatives, as it would include nuclei in other cell types with a different biology. For example, it might have led to a false notion that myonuclei undergo apoptosis during disuse atrophy (for references see 10 ), while in fact more precise methods indicate that the increase in apoptotic behaviour is limited to other cell types in the muscle tissue while myonuclei seems to be protected. 6,10,11 PCM1
labelling will provide a new simple tool for avoiding false identification of myonuclei in a complex tissue.
In conclusion, PCM1 staining provides a new simple and robust method for selectively and reliably labelling myonuclei in rodents and humans, eliminating the need for a detailed and often subjective assessment of the position 
| Human studies
For human studies, The Regional Committees for Medical and Health Research Ethics in Southeast Norway approved the study (2014/834), which was performed in accordance with the Declaration of Helsinki. All subjects signed a written informed consent prior to study participation.
| Transduction using recombinant adenoassociated virus serotype-6
To visualize myonuclei by an independent method, a custom AAV6 vector comprised of the human Alpha-Actin-1 (ACTA1) gene promoter and nuclear mCherry was constructed. The promoter region (3111 bp to 740 bp upstream of the transcription start site) for the ACTA1 gene was amplified by PCR and subcloned into the pCherry vector carrying a nuclear localization signal (NLS) upstream of the mCherry cassette. The expression cassette was then cloned into the pAAV6-Basic vector. The final construct was validated by Sanger sequencing (results not shown). Virus carrying the ACTA1 vector was produced by Vector Biolabs. For transduction, 6-week-old female NMRI mice (Janvier Labs, France) were injected with 5 9 10 9 genome copies of adeno-associated virus-6 in 20 lL sterile Dulbecco's phosphate-buffered saline (DPBS). Fourteen days after transduction, tibialis anterior (TA) muscles were isolated as described below.
| Functional overload by synergist ablation
Overload of rat plantaris and soleus muscles was induced by excising the distal 1/3 of the gastrocnemius, leaving all neural and blood supply to plantaris and soleus intact. Ablations were performed unilaterally, whereas the left foot not undergoing overload served as a contralateral control. Fourteen days after synergist ablation, the plantaris and soleus muscles were isolated as described below.
| Muscle isolation and sectioning
Muscles from 8-week-old untreated (Figure 1 and 3 
| Histochemistry
| PCM1
Sections retrieved from À80°C were allowed to equilibrate for 30 minutes at room temperature. Before staining, slides were pre-incubated with 2% BSA in PBS pH 7.4 for 30 minutes. Sections were stained with a Rabbit polyclonal antibody against PCM1 (1:1000 HPA023370, Sigma) in staining solution (5% BSA in PBS, 0.2% Igepal CA-630) overnight at 4°C. Next day, the sections were washed three times for 5 minutes in PBS and stained with an anti-rabbit secondary antibody (1:1000, ab150077, Abcam) in 2% BSA in PBS for 1 hour. Sections were washed three times for 10 minutes with PBS. For visualizing dystrophin, the sections were stained with supernatant containing a mouse monoclonal antibody diluted in staining buffer (1:20, MANDYS8 (8H11), Developmental Studies Hybridoma Bank) for 2 hours. The sections were then washed three times for 10 minutes with PBS and stained with an anti-mouse antibody (1:500, A-11005, Thermo Fisher) for 1 hour, followed by another washing step. Excess liquid was then carefully removed, and the sections were mounted with Fluoromount-G containing DAPI (0100-20, SouthernBiotech).
| mCherry-NLS and dystrophin/PCM1
Following removal from À80°C, sections from mCherry-NLS-transfected muscle were allowed to equilibrate for 30 minutes at room temperature followed by 5-min fixation with freshly made 4% formaldehyde (Thermo Fisher Scientific) in PBS pH 7.4. Immediately after fixation, the slides were briefly rinsed with PBS pH 7. in a buffer containing 2% BSA in PBS pH 7.4, for 1 hour, followed by a 3 9 10 minutes washing step with PBS. The slides were stained with a secondary antibody (1:500, ab150077, Abcam) followed by a 3 9 10 minutes washing step before being mounted and processed as above (Figure 4) .
| PAX7
Satellite cells were labelled by fixing with 4% freshly made formaldehyde (Thermo Fisher Scientific) for 5 minutes followed by epitope retrieval using a sodium citrate/ Tween buffer (10 mmol L À1 , pH 6.5, 0.05% Tween 20)
at 95°C for 30 minutes. Sections were stained overnight with antibody against PAX7 (Supernatant, Developmental Studies Hybridoma Bank) using a staining solution containing 50% supernatant diluted in PBS pH 7.4 supplemented with 2% BSA and 0.01% Triton X-100. Signal was obtained using the Tyramide Signal Enhancement (TSA) kit (Life Technologies) with a biotin-conjugated secondary antibody and streptavidin-horseradish peroxidase included within the kit. To visualize antibody-binding, TSA-Alexa Fluor 594 was used. Sections were then counterstained with DAPI and PCM1 as described in previous sections ( Figure 5 ).
| Microscopy and image analysis
All images were visualized using a 409 or 609 PlanApo objective (NA 1.3 and 1.35, respectively) on a FluoView FV 1000 confocal microscope (Olympus) using the FV1000 software (version 1.7a). For analysis through the different focal planes, images were acquired in a stepwise manner through the z-plane with a step size of 1.0 lm and a resolution of 800 9 800 pixels and laser scanning speed of 2,0 ls/pixel. For functional overload studies, images were captured with a resolution of 1024 9 1024 pixels and laser scanning speed of 2,0 ls/pixel; 8-11 images were acquired from each muscle, and 8-22 fibres were analysed from each image. All fibres with a complete dystrophin ring inside the image were included, excluding fibres with central nuclei or inconsistent dystrophin ring due to focal plane differences. The total number of myonuclei in each of the included fibres was counted, including only myonuclei that were both PCM1 and DAPI positive, irrespective of the DAPI staining appearing to be inside or outside the dystrophin ring. Cross-sectional area was measured on all included fibres. For comparing myonuclei identification with and without PCM1, nuclei in single focal planes were counted using the DAPI and dystrophin channel, using the mass centre inside the dystrophin inclusion criteria. The same images were also counted using PCM1 and the dystrophin channel. Images of PAX7-stained sections and transduced skeletal muscles were obtained using an Olympus BX-50WI compound microscope with a 40x (NA 0.3) water immersion objective. Images were acquired with an Andor iXion+ camera, controlled by Andor SOLIS software. Image processing was performed using ImageJ (NIH, USA), and image analysis was performed using Adobe Photoshop CS6 extended (Adobe Systems, USA). Analysis and 3D visualization were performed in Imaris 7.1 (Bitplane, USA).
| Western blotting
For protein extraction, muscles were excised and snap-frozen in liquid nitrogen. The frozen tissue was crushed with a mortar cooled on dry ice and resuspended in protein loading dye for the whole tissue analysis or PBS-based lysis buffer [PBS, pH 7.4, 1% Triton X-100 (Sigma), 0.1% Tween 20 (Sigma) with protease inhibitors (Complete Ultra EDTA-free tablets; Roche). The lysate was sonicated for 5 minutes in 30 seconds on and 30 seconds off cycles using a Bioruptor NextGen (Diagenode) at 5°C. For samples lysed in the PBS-based buffer, the lysate was centrifuged for 5 minutes at 13 000 g at 5°C. The soluble and insoluble fractions respectively were resuspended to equal volumes before subjected to SDS-PAGE and immunoblotting as described previously 30 using anti-PCM1 at a concentration of 1:250.
| Statistical procedures
For the overload experiment (n = 8 rats), comparison of overloaded and contralateral control leg was calculated by Student's two-tailed unpaired t test for both myonuclear number and cross-sectional area (CSA) using Graphpad Prism (version 7.0c). Statistical significance was accepted when P ˂ .05.
